Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...

The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...

The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.

List includes medications for diabetes, cancer, arthritis, and more ...

Still, the medications in the latest round of negotiations — which now includes “Part B” drugs given in doctors offices — ...

The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...

The Trump administration kicked off another round of Medicare drug price negotiations, while Kaiser Permanente agrees to pay ...

About 1.8 million people used one or more of the 15 drugs through Medicare Part D or Part B between November 2024 and October 2025, the CMS said. The batch of 15 meds accounted for about $27 billion ...

The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug ...

Tuesday's announcement is part of the Trump administration's efforts to reduce prescription drug costs for Americans, with ...

Fifteen prescription medications, including Botox and the diabetes drug Trulicity, will be the focus of federal price negotiations that could lower prices for Medicare patients.

The list has been announced by the Centers for Medicare & Medicaid Services (CMS) shortly after the reductions agreed for the ...